GLG Partners’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
BBA
KCM
GLG Partners's HRTX Position: Q4 2014 in Review
GLG Partners sold out of Heron Therapeutics (HRTX) in Q4 2014, closing a stake of 30,643 shares — an estimated $255K sold.
GLG Partners first reported a position in HRTX in Q1 2014 and held it in 3 quarters. The position peaked at $1.76M in Q1 2014. 64 funds tracked by Wall St. Rank hold HRTX as of Q4 2014.
- GLG Partners reported no remaining Heron Therapeutics position as of Q4 2014 after selling out during the quarter.
- GLG Partners sold 30,643 Heron Therapeutics shares in Q4 2014, an estimated $255K.
- GLG Partners first reported a position in Heron Therapeutics in Q1 2014 and held it in 3 quarters.
- GLG Partners's Heron Therapeutics position peaked at $1.76M in Q1 2014.
- 64 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2014.
Based on GLG Partners's 13F filing for Q4 2014, filed 17 Feb 2015.